Academic Journal
Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial
| Τίτλος: | Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial |
|---|---|
| Συγγραφείς: | Gold, MR, Lambiase, PD, El-Chami, MF, Knops, RE, Aasbo, JD, Bongiorni, MG, Russo, AM, Deharo, J-C, Burke, MC, Dinerman, J, Barr, CS, Shaik, N, Carter, N, Stoltz, T, Stein, KM, Brisben, AJ, Boersma, LVA, UNTOUCHED Investigators* |
| Πηγή: | Circulation , 143 (1) pp. 7-17. (2021) |
| Έτος έκδοσης: | 2021 |
| Συλλογή: | University College London: UCL Discovery |
| Θεματικοί όροι: | arrhythmias, cardiac, defibrillators, implantable, heart failure, primary prevention, sudden cardiac death, ventricular fibrillation, ventricular tachycardia |
| Περιγραφή: | BACKGROUND: The subcutaneous (S) implantable cardioverter-defibrillator (ICD) is safe and effective for sudden cardiac death prevention. However, patients in previous S-ICD studies had fewer comorbidities, had less left ventricular dysfunction, and received more inappropriate shocks (IAS) than in typical transvenous ICD trials. The UNTOUCHED trial (Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction) was designed to evaluate the IAS rate in a more typical, contemporary ICD patient population implanted with the S-ICD using standardized programming and enhanced discrimination algorithms. METHODS: Primary prevention patients with left ventricular ejection fraction ≤35% and no pacing indications were included. Generation 2 or 3 S-ICD devices were implanted and programmed with rate-based therapy delivery for rates ≥250 beats per minute and morphology discrimination for rates ≥200 and <250 beats per minute. Patients were followed for 18 months. The primary end point was the IAS-free rate compared with a 91.6% performance goal, derived from the results for the ICD-only patients in the MADIT-RIT study (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy). Kaplan-Meier analyses were performed to evaluate event-free rates for IAS, all-cause shock, and complications. Multivariable proportional hazard analysis was performed to determine predictors of end points. RESULTS: S-ICD implant was attempted in 1116 patients, and 1111 patients were included in postimplant follow-up analysis. The cohort had a mean age of 55.8±12.4 years, 25.6% were women, 23.4% were Black, 53.5% had ischemic heart disease, 87.7% had symptomatic heart failure, and the mean left ventricular ejection fraction was 26.4±5.8%. Eighteen-month freedom from IAS was 95.9% (lower confidence limit, 94.8%). Predictors of reduced incidence of IAS were implanting the most recent generation of device, using the 3-incision technique, no history of atrial fibrillation, and ischemic cause. ... |
| Τύπος εγγράφου: | article in journal/newspaper |
| Περιγραφή αρχείου: | text |
| Γλώσσα: | English |
| Relation: | https://discovery.ucl.ac.uk/id/eprint/10120730/1/CIRCULATIONAHA.120.048728.pdf; https://discovery.ucl.ac.uk/id/eprint/10120730/ |
| Διαθεσιμότητα: | https://discovery.ucl.ac.uk/id/eprint/10120730/1/CIRCULATIONAHA.120.048728.pdf https://discovery.ucl.ac.uk/id/eprint/10120730/ |
| Rights: | open |
| Αριθμός Καταχώρησης: | edsbas.C1237228 |
| Βάση Δεδομένων: | BASE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://discovery.ucl.ac.uk/id/eprint/10120730/1/CIRCULATIONAHA.120.048728.pdf# Name: EDS - BASE (ns324271) Category: fullText Text: View record from BASE |
|---|---|
| Header | DbId: edsbas DbLabel: BASE An: edsbas.C1237228 RelevancyScore: 906 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 906.347900390625 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Gold%2C+MR%22">Gold, MR</searchLink><br /><searchLink fieldCode="AR" term="%22Lambiase%2C+PD%22">Lambiase, PD</searchLink><br /><searchLink fieldCode="AR" term="%22El-Chami%2C+MF%22">El-Chami, MF</searchLink><br /><searchLink fieldCode="AR" term="%22Knops%2C+RE%22">Knops, RE</searchLink><br /><searchLink fieldCode="AR" term="%22Aasbo%2C+JD%22">Aasbo, JD</searchLink><br /><searchLink fieldCode="AR" term="%22Bongiorni%2C+MG%22">Bongiorni, MG</searchLink><br /><searchLink fieldCode="AR" term="%22Russo%2C+AM%22">Russo, AM</searchLink><br /><searchLink fieldCode="AR" term="%22Deharo%2C+J-C%22">Deharo, J-C</searchLink><br /><searchLink fieldCode="AR" term="%22Burke%2C+MC%22">Burke, MC</searchLink><br /><searchLink fieldCode="AR" term="%22Dinerman%2C+J%22">Dinerman, J</searchLink><br /><searchLink fieldCode="AR" term="%22Barr%2C+CS%22">Barr, CS</searchLink><br /><searchLink fieldCode="AR" term="%22Shaik%2C+N%22">Shaik, N</searchLink><br /><searchLink fieldCode="AR" term="%22Carter%2C+N%22">Carter, N</searchLink><br /><searchLink fieldCode="AR" term="%22Stoltz%2C+T%22">Stoltz, T</searchLink><br /><searchLink fieldCode="AR" term="%22Stein%2C+KM%22">Stein, KM</searchLink><br /><searchLink fieldCode="AR" term="%22Brisben%2C+AJ%22">Brisben, AJ</searchLink><br /><searchLink fieldCode="AR" term="%22Boersma%2C+LVA%22">Boersma, LVA</searchLink><br /><searchLink fieldCode="AR" term="%22UNTOUCHED+Investigators*%22">UNTOUCHED Investigators*</searchLink> – Name: TitleSource Label: Source Group: Src Data: Circulation , 143 (1) pp. 7-17. (2021) – Name: DatePubCY Label: Publication Year Group: Date Data: 2021 – Name: Subset Label: Collection Group: HoldingsInfo Data: University College London: UCL Discovery – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22arrhythmias%22">arrhythmias</searchLink><br /><searchLink fieldCode="DE" term="%22cardiac%22">cardiac</searchLink><br /><searchLink fieldCode="DE" term="%22defibrillators%22">defibrillators</searchLink><br /><searchLink fieldCode="DE" term="%22implantable%22">implantable</searchLink><br /><searchLink fieldCode="DE" term="%22heart+failure%22">heart failure</searchLink><br /><searchLink fieldCode="DE" term="%22primary+prevention%22">primary prevention</searchLink><br /><searchLink fieldCode="DE" term="%22sudden+cardiac+death%22">sudden cardiac death</searchLink><br /><searchLink fieldCode="DE" term="%22ventricular+fibrillation%22">ventricular fibrillation</searchLink><br /><searchLink fieldCode="DE" term="%22ventricular+tachycardia%22">ventricular tachycardia</searchLink> – Name: Abstract Label: Description Group: Ab Data: BACKGROUND: The subcutaneous (S) implantable cardioverter-defibrillator (ICD) is safe and effective for sudden cardiac death prevention. However, patients in previous S-ICD studies had fewer comorbidities, had less left ventricular dysfunction, and received more inappropriate shocks (IAS) than in typical transvenous ICD trials. The UNTOUCHED trial (Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction) was designed to evaluate the IAS rate in a more typical, contemporary ICD patient population implanted with the S-ICD using standardized programming and enhanced discrimination algorithms. METHODS: Primary prevention patients with left ventricular ejection fraction ≤35% and no pacing indications were included. Generation 2 or 3 S-ICD devices were implanted and programmed with rate-based therapy delivery for rates ≥250 beats per minute and morphology discrimination for rates ≥200 and <250 beats per minute. Patients were followed for 18 months. The primary end point was the IAS-free rate compared with a 91.6% performance goal, derived from the results for the ICD-only patients in the MADIT-RIT study (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy). Kaplan-Meier analyses were performed to evaluate event-free rates for IAS, all-cause shock, and complications. Multivariable proportional hazard analysis was performed to determine predictors of end points. RESULTS: S-ICD implant was attempted in 1116 patients, and 1111 patients were included in postimplant follow-up analysis. The cohort had a mean age of 55.8±12.4 years, 25.6% were women, 23.4% were Black, 53.5% had ischemic heart disease, 87.7% had symptomatic heart failure, and the mean left ventricular ejection fraction was 26.4±5.8%. Eighteen-month freedom from IAS was 95.9% (lower confidence limit, 94.8%). Predictors of reduced incidence of IAS were implanting the most recent generation of device, using the 3-incision technique, no history of atrial fibrillation, and ischemic cause. ... – Name: TypeDocument Label: Document Type Group: TypDoc Data: article in journal/newspaper – Name: Format Label: File Description Group: SrcInfo Data: text – Name: Language Label: Language Group: Lang Data: English – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: https://discovery.ucl.ac.uk/id/eprint/10120730/1/CIRCULATIONAHA.120.048728.pdf; https://discovery.ucl.ac.uk/id/eprint/10120730/ – Name: URL Label: Availability Group: URL Data: https://discovery.ucl.ac.uk/id/eprint/10120730/1/CIRCULATIONAHA.120.048728.pdf<br />https://discovery.ucl.ac.uk/id/eprint/10120730/ – Name: Copyright Label: Rights Group: Cpyrght Data: open – Name: AN Label: Accession Number Group: ID Data: edsbas.C1237228 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsbas&AN=edsbas.C1237228 |
| RecordInfo | BibRecord: BibEntity: Languages: – Text: English Subjects: – SubjectFull: arrhythmias Type: general – SubjectFull: cardiac Type: general – SubjectFull: defibrillators Type: general – SubjectFull: implantable Type: general – SubjectFull: heart failure Type: general – SubjectFull: primary prevention Type: general – SubjectFull: sudden cardiac death Type: general – SubjectFull: ventricular fibrillation Type: general – SubjectFull: ventricular tachycardia Type: general Titles: – TitleFull: Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gold, MR – PersonEntity: Name: NameFull: Lambiase, PD – PersonEntity: Name: NameFull: El-Chami, MF – PersonEntity: Name: NameFull: Knops, RE – PersonEntity: Name: NameFull: Aasbo, JD – PersonEntity: Name: NameFull: Bongiorni, MG – PersonEntity: Name: NameFull: Russo, AM – PersonEntity: Name: NameFull: Deharo, J-C – PersonEntity: Name: NameFull: Burke, MC – PersonEntity: Name: NameFull: Dinerman, J – PersonEntity: Name: NameFull: Barr, CS – PersonEntity: Name: NameFull: Shaik, N – PersonEntity: Name: NameFull: Carter, N – PersonEntity: Name: NameFull: Stoltz, T – PersonEntity: Name: NameFull: Stein, KM – PersonEntity: Name: NameFull: Brisben, AJ – PersonEntity: Name: NameFull: Boersma, LVA – PersonEntity: Name: NameFull: UNTOUCHED Investigators* IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Type: published Y: 2021 Identifiers: – Type: issn-locals Value: edsbas – Type: issn-locals Value: edsbas.oa Titles: – TitleFull: Circulation , 143 (1) pp. 7-17. (2021 Type: main |
| ResultId | 1 |